Christophe Claude Parsy;Guillaume Brandt;Daniel Da Costa;Thierry C;David Dukhan;Claire Pierra;John P. Billelo;Houcine Rahali;Francois-Rene Alexandre;Jean-Laurent Paparin;Michel Derock;Cyril B. Dousson
发明人:
Cyril B. Dousson,David Dukhan,John P. Billelo,Christophe Claude Parsy,Claire Pierra,Francois-Rene Alexandre,Guillaume Brandt,Daniel Da Costa,Houcine Rahali,Jean-Laurent Paparin,Michel Derock,Thierry C
申请号：
US13434503
公开号：
US20120252721A1
申请日:
2012.03.29
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Provided herein are methods for treating or preventing drug-resistant hepatitis C virus infection in a subject, which comprises administering to the subject a 5,5-fused heteroarylene hepatitis C virus inhibitor compound, for example, of Formula I, IA, or IB.
